Company / FCF Margin
Cartesian Therapeutics, Inc. FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-84.2%
FY2025
5-year range
-771.0% / 205.3%
FY2021-FY2025
Trend
+57.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin returned to growth in FY2025 after 2 years of decline, reaching -84.2%.
Based on SEC 10-K filings.
-84.2% in FY2025 with a 5-year CAGR of +6565.3%.
Declined from -72.3% to -84.2% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -289.5pp
- 5-Year Change
- +6565.3pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin increased 57.4% year-over-year.
- Peak fcf margin was recorded in FY2022.
- Lowest fcf margin in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -84.2% | +57.4% |
| FY2024 | -197.5% | -173.4% |
| FY2023 | -72.3% | -135.2% |
| FY2022 | 205.3% | +126.6% |
| FY2021 | -771.0% | +88.4% |
| FY2020 | -6649.5% | +73.9% |
| FY2019 | -25487.4% | -5900.3% |
| FY2016 | -424.8% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026